2. Metabolic Enzyme/Protease Apoptosis
  3. Lactate Dehydrogenase Apoptosis
  4. Oxamic acid

Oxamic acid  (Synonyms: Oxamidic acid)

Cat. No.: HY-W013032 Purity: ≥98.0%
SDS
COA
Handling Instructions Technical Support

Oxamic acid is a lactate dehydrogenase-A (LDH-A) inhibitor. Oxamic acid shows anti-tumor activity, and anti-proliferative activity against cancer cells, and can induce apoptosis.

For research use only. We do not sell to patients.

Oxamic acid Chemical Structure

Oxamic acid Chemical Structure

CAS No. : 471-47-6

Size Price Stock Quantity
100 mg In-stock
500 mg In-stock
1 g   Get quote  
5 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 19 publication(s) in Google Scholar

Other Forms of Oxamic acid:

Oxamic acid Related Antibodies

Top Publications Citing Use of Products

    Oxamic acid purchased from MedChemExpress. Usage Cited in: J Hazard Mater. 2025 Jan 21:488:137310.  [Abstract]

    After treating BV-2 cells with 0 or 10 µM oxamate (OX) for 2 h, cells were treated with 0 % or 6 % CSE for 24 h. Representative immunoblot images of NLRP3.

    Oxamic acid purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Jun 20:75:103246.  [Abstract]

    Oxamic acid (Ox) (20 mM; 24 h) treatment in AGEs-induced mTEC dramatically downregulated the levels of Pan kla and H3K14la.

    Oxamic acid purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Jun 20:75:103246.  [Abstract]

    Oxamic acid (Ox) (20 mM; 24 h) markedly inhibits the expression of fibrogenic genes (snail1, snail2, and twist1) in AGEs-stimulated mTEC, but no significant effect on quiescent cells.

    Oxamic acid purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Jun 20:75:103246.  [Abstract]

    Oxamic acid (Ox) (0.75 g/kg; i.p.; once daily for 4 weeks). Immunofluorescent staining of E-cadherin (red), ɑ-SMA (green), and DAPI (blue).

    Oxamic acid purchased from MedChemExpress. Usage Cited in: Theranostics. 2023 Jul 3;13(11):3856-3871.  [Abstract]

    Oxamic acid (10 mM) reverses the increase of Klac-HMGB1 levels in H/R-Ko hepatocytes.

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Oxamic acid is a lactate dehydrogenase-A (LDH-A) inhibitor. Oxamic acid shows anti-tumor activity, and anti-proliferative activity against cancer cells, and can induce apoptosis[1][2][3].

    In Vitro

    Oxamic acid suppresses the proliferation, migration and invasion of both A2780 and SKOV3 cells[1].
    Oxamic acid (10 μM; 24-72 h) inhibits cell proliferation in a dose- and time-dependent manner in both NPC cancer cells[2].
    Oxamic acid (0-100 mM; 24 h) induces cell cycle arrest in the G2/M phase in CNE-1 and CNE-2 cells[2].
    Oxamic acid (0-100 mM; 48 h) induces apoptosis via caspase-3 activation and the mitochondrial pathway in NPC cells[2].
    Oxamic acid (0-100 mM; 24 h) increases ROS levels in NPC cells[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Oxamic acid Related Antibodies

    Cell Proliferation Assay[2]

    Cell Line: CNE-1 and CNE-2 cells
    Concentration: 10 μM
    Incubation Time: 24-72 hours
    Result: Showed IC50s of 74.6, 32.4 and 17.8 mM and 62.3, 44.5, 31.6 mM at 24, 48 and 72 h in the CNE-1 and CNE-2 cancer cells, respectively.

    Apoptosis Analysis[2]

    Cell Line: CNE-1 and CNE-2 cells
    Concentration: 0, 20, 50 and 100 mM
    Incubation Time: 48 hours
    Result: Showed the increasement of early and late apoptotic cells in a dose-dependent manner.
    Increased the expression of pro-apoptotic Bax and cleaved-caspase-3, while reduced the anti-apoptotic signals of Bcl-2 and pro-caspase-3.

    Cell Cycle Analysis[2]

    Cell Line: CNE-1 and CNE-2 cells
    Concentration: 0, 20, 50 and 100 mM
    Incubation Time: 24 hours
    Result: Showed a dose-dependent increase in the numbers of CNE-1 and CNE-2 cells in the G2/M phase.
    In Vivo

    Oxamic acid (intraperitoneal injection; 750 mg/kg; once daily; 3 w) treatment improves the efficacy of tumor inhibition in vivo when combined with irradiation treatment[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Female Balb/c nude mice injected with CNE-1 cells[2]
    Dosage: 750 mg/kg
    Administration: Intraperitoneal injection; 750 mg/kg; once daily; 3 weeks
    Result: Inhibited the tumor growth when compared to either oxamate alone or irradiation alone.
    Molecular Weight

    89.05

    Formula

    C2H3NO3
    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    NC(C(O)=O)=O
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.
    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    H2O : 50 mg/mL (561.48 mM; Need ultrasonic)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 11.2296 mL 56.1482 mL 112.2965 mL
    5 mM 2.2459 mL 11.2296 mL 22.4593 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
    Purity & Documentation

    Purity: 99.98%

    SDS (760 KB)

    COA (245 KB) RP-HPLC (293 KB)

    Handling Instructions (2659 KB)
    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O 1 mM 11.2296 mL 56.1482 mL 112.2965 mL 280.7411 mL
    5 mM 2.2459 mL 11.2296 mL 22.4593 mL 56.1482 mL
    10 mM 1.1230 mL 5.6148 mL 11.2296 mL 28.0741 mL
    15 mM 0.7486 mL 3.7432 mL 7.4864 mL 18.7161 mL
    20 mM 0.5615 mL 2.8074 mL 5.6148 mL 14.0371 mL
    25 mM 0.4492 mL 2.2459 mL 4.4919 mL 11.2296 mL
    30 mM 0.3743 mL 1.8716 mL 3.7432 mL 9.3580 mL
    40 mM 0.2807 mL 1.4037 mL 2.8074 mL 7.0185 mL
    50 mM 0.2246 mL 1.1230 mL 2.2459 mL 5.6148 mL
    60 mM 0.1872 mL 0.9358 mL 1.8716 mL 4.6790 mL
    80 mM 0.1404 mL 0.7019 mL 1.4037 mL 3.5093 mL
    100 mM 0.1123 mL 0.5615 mL 1.1230 mL 2.8074 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    Oxamic acid Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    Oxamic acid471-47-6Oxamidic acidLactate DehydrogenaseApoptosisLDHanti-tumor activityanti-proliferative activityinduce apoptosisCNE-1CNE-2A2780SKOV3Inhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Requested Quantity *

    Applicant Name *

    		 

    Salutation

    Email Address *

    		 

    Phone Number *

    Department

    		 

    Organization Name *

    City

    State

    Country or Region *

    		      

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Oxamic acid
    Cat. No.:
    HY-W013032
    Quantity:
    MCE Japan Authorized Agent:

    Customer Review

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Lot #

    Applicant Name *

    		 

    Email Address *

    Phone Number

    		 

    Department *

    Organization Name *

    		 

    Country or Region *

    Remarks

    SAFETY DATA SHEET (SDS)

    English - EN (760 KB) Français - FR (760 KB) Deutsch - DE (760 KB) Norwegian - NO (760 KB) Español - ES (760 KB) Swedish - SV (760 KB)

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.